Authorized generics are brand-name drugs sold under a generic label. As patent cliffs hit in 2025-2030, their role is shifting from market control to managed transition - driven by FDA policy, U.S. manufacturing incentives, and growing pressure for affordable drugs.
Authorized generics are identical copies of brand-name drugs made by the same manufacturer, launched to compete with generic versions after patent expiration. They lower prices, reduce patient confusion, and help brands retain market share.
Authorized generics often cost less than first-to-file generics due to early competition. Learn how these two types of generic drugs compare in price, quality, and market impact-so you can save money on prescriptions.